ED
MATX icon

Exane Derivatives’s Matsons MATX Stock Holding History

Exane Derivatives’s Portfolio MATX Stock Details MATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$14.1K Sell
193
-271
-58% -$23.3K 0.01% 379
2022
Q1 		$56K Buy
464
+2
+0.4% +$202 0.02% 556
2021
Q4 		$41.6K Buy
+462
New +$39.4K 0.01% 514

Other funds holding MATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Exane Derivatives's MATX Position: Q2 2022 in Review

Exane Derivatives reduced its Matsons (MATX) stake by 58% in Q2 2022, selling an estimated $23.3K and leaving 193 shares worth $14.1K. The position accounts for 0.01% of the portfolio, ranked #379.

Exane Derivatives first reported a position in MATX in Q4 2021 and has held it in 3 quarters since. The position peaked at $56K in Q1 2022. 324 funds tracked by Wall St. Rank hold MATX as of Q2 2022.

  • Exane Derivatives held 193 shares of Matsons worth $14.1K as of Q2 2022.
  • Exane Derivatives sold 271 Matsons shares in Q2 2022, an estimated $23.3K.
  • Matsons made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #379 holding.
  • Exane Derivatives first reported a position in Matsons in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's Matsons position peaked at $56K in Q1 2022.
  • 324 funds tracked by Wall St. Rank held Matsons as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.